Phosphagenics already have the inside running here with their TPM-enhanced topical cream, which has been released in India as Vovaren (Novartis) and Instanac (Themis) gel. IMO Novartis will evaluate the take-up and effectiveness of the Vovaren product before introducing it into their Voltaren markets worldwide.
That's not to exclude the adoption of a next-gen OBJ-powered patch for strong joint/muscle pain indications.
- Forums
- ASX - By Stock
- WFL
- gsk & novartis
gsk & novartis, page-4
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add WFL (ASX) to my watchlist
|
|||||
Last
0.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $1.478M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
WFL (ASX) Chart |
Day chart unavailable